Teleosts are unique among vertebrates due to their indeterminate muscle growth, i.e., continued production of neonatal muscle fibers until death. However, the molecular mechanism(s) underlying this property is unknown. Here, we focused on the torafugu (Takifugu rubripes) myosin heavy chain gene, MYHM2528-1, which is specifically expressed in neonatal muscle fibers produced by indeterminate muscle growth. We examined the flanking region of MYHM2528-1 through an in vivo reporter assay using zebrafish (Danio rerio) and identified a 2100 bp 5′-flanking sequence that contained sufficient promoter activity to allow specific gene expression.
1.

Introduction
Skeletal muscle comprises a large portion of the mass of vertebrates. The bulk of vertebrate growth, therefore, depends on an increase in skeletal muscle mass during a species's lifespan. Skeletal muscles display two types of growth patterns, hypertrophy and hyperplasia. The former is characterized by an increase in the size of existing muscle fibers (myocytes) while the latter results in an increase in the number of muscle fibers. In mammals, however, the contribution of hyperplasia to muscle growth is quite small in the postnatal period and further growth primarily depends on hypertrophy (Rowe and Goldspink, 1969) , resulting in limited growth and a definitive body size. Production of new muscle fibers after the neonatal period in mammals is observed only in the regeneration of injured muscle (reviewed by Dhawan and Rando, 2005) . Conversely, in teleost skeletal muscles, both hyperplasia and hypertrophy occur throughout the organism's lifespan Mommsen, 2001) . This 'indeterminate' muscle growth provides teleosts with a vast potential to increase their body size, in some cases from a few milligrams to a hundred kilograms (Johnston, 2001 ). In addition, the degree of muscle growth is highly variable among teleost species, resulting in a magnitude of differences in adult body size. Thus, the indeterminate production of muscle fibers is an important phenomenon that dictates teleost growth.
The mechanisms underlying indeterminate muscle growth are also relevant to understanding age-related muscular disorders in mammals. Mammalian skeletal muscles undergo marked senescence called sarcopenia, the loss of muscle mass due to an age-associated decrease in the number and size of muscle fibers. Sarcopenia in humans is a severe problem globally, associated with increasing age Manini, 2008, 2010) . Various studies using mammalian models such as mice and rats have identified several genes involved in senescence, with relevant genetic modifications resulting in a marked delay in the senescence of various organs, including skeletal muscle (Froehlich et al., 2013a) . However, these modified mammalian models merely display a delay in senescence and eventually still achieve a severe sarcopenia phenotype. In this regard, teleosts are an attractive model because the naturally negligible senescence of their skeletal muscles presents a potentially powerful system through which a method to inhibit sarcopenia can be discovered (Froehlich et al., 2013a) . However, the molecular mechanisms responsible for the indeterminate muscle growth found in teleosts are completely unknown.
Myosin heavy chain (MYH) is a subunit of myosin, the most abundant protein in skeletal muscle. Many isoforms of MYH exist, and their variation in expression is the primary determinant of the differential physiological properties of muscle fibers, such as slow vs. fast twitch (Weiss et al., 1999) . The expression patterns of MYH isoforms also change along with the progression of growth stages such as embryonic, neonatal, and adult (Berg et al., 2001) . Interestingly, several studies have reported that new muscle fibers (neonatal muscle fibers) produced by post-embryonic hyperplasia express specific MYH isoforms in common carp (Ennion et al., 1995) , sea bream (Rowlerson et al., 1997) , and zebrafish (Rowlerson et al., 1997) . Our previous studies also identified a MYH gene (MYH), MYHM2528-1, in the torafugu (Takifugu rubripes) genome with specific expression in neonatal muscle fibers produced by muscle hyperplasia at the larval, juvenile and adult stages (Akolkar et al., 2010; Asaduzzaman et al., 2013) . MYHM2528-1 was expressed in dorsal and ventral extreme, a region producing neonatal muscle fibers by stratified hyperplasia at larval stage and subsequently in small diameter muscle fibers generated by mosaic hyperplasia at the juvenile stages (Asaduzzaman et al., 2013) . In adult torafugu, both fast and slow muscles expressed MYHM2528-1 but the expression was restricted to small diameter neonatal fibers, implying that this gene is associated with muscle hyperplasia from larval to adult stages (Akolkar et al., 2010) . Therefore, understanding the mechanisms of MYHM2528-1 transcription regulation will provide a basis to dissect the molecular network involved in the production of neonatal muscle fibers through post-embryonic hyperplasia.
In the present study, we examined the torafuguMYHM2528-1 promoter via an in vivo reporter assay using zebrafish and demonstrated its role in the activation of gene expression specifically in neonatal muscle fibers produced by larval and post-larval muscle hyperplasia among different fish species.
Results
Determination of the MYHM2528-1 transcription start site
We first determined the transcription start site to characterize the 5′ flanking region of MYHM2528-1. Based on the 5′RACE, the transcription start site was determined to be 502 bp from the start codon (Fig. S1 ). Exons 1 and 2 are transcribed as an untranslated region, and the start codon is located in exon3 ( Fig. S1 and Fig. 1 ).
2.2.
The 2100 bp 5′-flanking region of torafugu MYHM2528-1 is the minimal promoter necessary to induce gene expression in zebrafish skeletal muscle To map the minimal promoter necessary to induce expression of MYHM2528-1, a series of 5′ distal deletion constructs of the flanking sequence of MYHM2528-1, namely P5000, P4000, P3000, P2500, P2300, P2100, P1500, P1000, and P600, respectively (Fig. 1) , were microinjected into fertilized eggs of zebrafish as an in vivo reporter assay. For P5000,~97% of the injected embryos displayed strong EGFP expression along skeletal muscle fibers (Figs. 2A, B and 3A) . The EGFP expression was detected at 1 dpf and continued to be expressed in the whole myotomal region of larva at 2 dpf ( Fig. S2A-E) . At 3 dpf, EGFP was found to be expressed in the craniofacial and myotomal muscles (Figs. 2K and S2E) . In the myotomal region, both slow and fast muscle fibers expressed EGFP (Fig. S3) . Although almost the same expression pattern was observed in zebrafish larvae injected with P5000 through P600 (Fig. 2) , 5′ flanking regions shorter than 2100 bp resulted in a significant reduction in EGFP expression in the myotomal muscle fibers (Figs. 2M-R and S2). As shown in Fig. 3A , the ratio of EGFP-expressing larvae per injected larvae of P1500-P600 was significantly reduced compare with those of P5000-P2100 injected larvae. In addition, the number of EGFP-positive muscle fibers per embryo was markedly reduced in P1500-P600 injected larvae . This finding indicates that cis-acting element(s) in between −2100 and −600 bp in the 5′ flanking region participate in the promoter activity of MYHM2528-1.
We screened for the putative binding sites of several myogenesis-related transcription factors within the 2100 bp sequence and found two MyoD, four myocyte enhancer element 2 (MEF2), two paired box 3 (Pax3), and three nuclear factor of activated T-cell (NFAT) binding sites ( Figs. 1 and S1 ). The reduced promoter activity for the successive deletion of 5′ flanking region from P2100 (Fig. 3) indicates that any or combination of these cis-elements might be involved in the transcriptional regulation of MYHM2528-1.
2.3.
MYHM2528-1 promoter activity in zebrafish larvae
To confirm the specific activity of the MYHM2528-1 promoter in post-embryonic muscle hyperplasia, a stable transgenic zebrafish line, Tg:MYHM2528-1:EGFP, was established using the P2100 construct and temporal and spatial EGFP expression was analyzed. Similar to the in vivo reporter assay (Fig. S2) , Tg:MYHM2528-1:EGFP displayed EGFP expression at 1 dpf (Fig. 4A, B) . After hatching at 2dpf, EGFP continued to be expressed in the whole myotomal region of the larva (Fig. 4C ). Observation with a fluorescent microscope also confirmed that Tg:MYHM2528-1:EGFP expressed EGFP in the whole myotomal region (Fig. 4D ) and craniofacial muscles (Fig. 4E ) at 3 dpf.
In teleosts, slow and fast muscle fibers occupy distinct regions of the myotomal skeletal muscle (Bone, 1978) . Fast muscle fibers comprise the deep portion of the myotome, which makes up most of the trunk musculature. Slow muscle fibers are segregated into a wedge-shaped region of the myotome surface at the lateral end of the horizontal myoseptum. Furthermore, fast and slow muscles have distinct developmental lineages (Devoto et al., 1996) and patterns of post-embryonic growth. In fast muscles of teleost larva, the apical surface region actively produces neonatal muscle fibers via hyperplasia (Rowlerson et al., 1995) . On the other hand, the slow muscles of teleost larva form a monolayer at the myotome surface, and the dorsal and ventral edge of the layer produce neonatal muscle fibers via hyperplasia (Barresi et al., 2001) . Figure 5 shows the immunohistochemistry of Tg:MYHM2528-1: EGFP at the larval stage (3dpf) to clarify the type and position of EGFP-positive muscle fibers. Slow muscle fibers at this stage formed a monolayer at surface of myotome ( Fig. 5A-C) as described. Most slow muscle fibers were EGFP negative, but a fiber Fig. 1 -Schematic of reporter constructs used in this study. A genomic region located 5000 bp upstream from the start codon of torafugu MYHM2528-1 amplified by PCR and inserted into an EGFP reporter vector (P5000). Serial deletion constructs containing 4000 (P4000), 3000 (P3000), 2500 (P2500), 2300 (P2300), 2100 (P2100), 1600 (P1600), 1000 (P1000), and 600 (P600) bp of the 5′-flanking sequence from the start codon, respectively, were also constructed. All constructs contain the 5′ untranslated region of MYHM2528-1 encoded by exons one, two, and part of three. Putative binding sites of representative muscle differentiation-related transcription factors, nuclear factor of activated T-cell (NFAT), MyoD, myocyte enhancer element 2 (MEF2), and paired box 3 (Pax3), are plotted on the P2100-P600 constructs. at the dorsal edge expressed EGFP ( Fig. 5D-F, arrowhead) . In fast muscle, many muscle fibers expressed EGFP, but their distribution was predominant in the apical surface region ( Fig. 5G-I ). In Fig. 5K and L, the slow muscle fibers at the dorsal edge (not stained in red by F310 antibody) also expressed EGFP, as indicated by arrowheads. Consequently, the distribution of EGFP-expressing muscle fibers was consistent with the myogenic zone via hyperplasia at the teleost larval stage. 
2.4.
MYHM2528-1 promoter activity in juvenile and adult zebrafish
After the larval stage, fast and slow muscles of teleosts still show different hyperplastic growth patterns. In fast muscle, myogenic cells scattered among existing muscle fibers produce neonatal muscle fibers. This growth pattern is termed mosaic hyperplasia (Rowlerson and Veggetti, 2001; Rowlerson et al., 1995) . On the other hand, in slow muscle, the myogenic region is positioned near the septum between slow and fast fibers and produces neonatal slow muscle fibers (Rowlerson et al., 1995) . Figure 6A illustrates the distribution of slow and fast muscles in a transverse section of the teleost trunk. It should be noted that the duration of post-embryonic muscle hyperplasia also differs between fast and slow muscles. Recruitment of neonatal muscle fibers in fast muscle ceases at a definitive size (Fernandes et al., 2005; Johnston et al., 2001; Weatherley et al., 1988) . In contrast, the number of slow muscle fibers continually increases with fish length ). In the case of zebrafish, post-larval muscle hyperplasia in fast muscle stops at approximately 17 mm standard length (SL) (Fig. 6B) (Lee, 2010) .
Immunohistochemistry was performed to clarify the position of EGFP-positive muscle fibers at post-larval (juvenile) and adult stages of Tg:MYHM2528-1:EGFP. At the early juvenile stage (20 dpf, 10 mm SL), EGFP expression in fast muscle was observed in small diameter fibers between large existing muscle fibers (Fig. 6C,D,G,H) . In the lateral slow and elector-depressor (ED) slow muscles of both the early and late juvenile stages of zebrafish development, EGFP expression was observed near the septum of slow and fast muscles (Fig. 6E,F) . The distribution of EGFP-positive muscle fibers overlaps the myogenic regions at the post-larval stage mentioned earlier, as well as the expression pattern of endogenous MYHM2528-1 in the torafugu (Akolkar et al., 2010; Asaduzzaman et al., 2013) . Consistent with the difference in the growth pattern between slow and fast muscles (Fig. 6B) , promoter activity was not observed in fast muscle (Fig. 6I ,J,L,M,O) but in slow muscle (Fig. 6K,N ,P,Q) at the late juvenile (40 dpf, 17 mm SL) and adult stage (60 dpf, 25 mm SL), respectively.
Taken together with the EGFP expression pattern in the larvae and juveniles of Tg:MYHM2528-1:EGFP, we concluded that 2100 bp from the start codon of MYHM2528-1 is enough functional promoter to allow gene expression specifically in neonatal muscle fibers produced by larval and post-larval muscle hyperplasia.
2.5.
MYHM2528-1 promoter works in secondary myogenesis
In zebrafish larvae, slow muscle fibers are subdivided into two components. One component consists of primary slow muscle fibers that differentiated from adaxial cells at embryonic development (Devoto et al., 1996) . The other component is secondary slow muscle fibers. After formation of the primary slow muscle, secondary slow muscle fibers are produced via post-embryonic muscle hyperplasia (Elworthy et al., 2008) . Here, we examined that Tg:MYHM2528-1:EGFP transgenic fish did express EGFP in secondary slow muscle fibers.
Adaxial cells are found adjacent to the axial midline, notochord. Adaxial cells differentiate to slow muscle progenitors at the position and then migrate laterally to form superficial monolayer of slow muscle fibers (Devoto et al., 1996) . We observed adaxial cell-derived slow muscle progenitors in Tg:MYHM2528-1:EGFP transgenic fish. At 10 somite stage (Fig. 7A) , adaxial cell-derived slow muscle progenitors still attached notochord showing adaxial cell-like pyramidal shape, and expressed slow-type MYH as stained by F59 antibody (Fig. 7B) . However, these adaxial cell-derived slow muscle progenitors did not express any EGFP (Fig. 7C,D) .
Hh signaling is an important cascade for slow muscle development in vertebrates. In zebrafish myogenesis, primary slow muscle fibers require Hh signaling whereas secondary slow muscle fibers are produced without the signaling. We examined the Hh signaling dependency of EGFP-expressing muscle fibers in Tg:MYHM2528-1:EGFP larvae. Cyclopamine is a well-known inhibitor of Hh signaling (Chen et al., 2002; Incardona et al., 1998) . After treatment with cyclopamine at 2.0, 4.0, 6.0 and 10 µg mL −1 , no change was observed in the survival rate of larvae with that in untreated control larvae. Cyclopamine treated larvae showed little reduction in EGFP expression compared to the control (Fig. S4A-G) . Immunohistochemistry was performed on the cross section by using 10 µg mL −1 cyclopamine treated larvae. Adaxial cell-derived primary slow muscle fibers along with the lateral superficial regions disappeared in cyclopamine treated larvae (Fig. S4H) . Only secondary slow muscle fiber at dorsal extreme was stained with F59 antibody and expressed EGFP (Fig. S4H-K) . Taken together, we concluded that Tg:MYHM2528-1:EGFP larvae expressed EGFP in secondarily slow muscle fibers but not in primary slow muscle fibers, indicating that MYHM2528-1 promoter activity is involved in post-embryonic hyperplasia. Partial reduction of EGFP expression in cyclopamine treated larvae might be due to the reduction of a subset of secondary slow muscle fibers. According to Elworthy et al. (2008) , the zebrafish secondary slow muscle fibers can be further divided into two components, one component does not depend on Hh signaling but another component depends on the Hh signaling.
Discussion
Skeletal muscles are not only important as the primary organ involved in mobility but are also being recognized as a prominent tissue with the capacity to influence aging and lifespan (Demontis and Perrimon, 2010; Demontis et al., 2013) . It has been shown that the mortality rate and pathogenesis of various age-related diseases are associated with the functional status and mass of skeletal muscle in humans. In mammals, however, the growth and regeneration capacity of skeletal muscle quickly decreases after birth (Rowe and Goldspink, 1969; Schultz, 1996) , and skeletal muscle mass severely declines during aging. In this regard, indeterminate growth, continuous production of neonatal muscle fibers until death, is a rare characteristic of teleost skeletal muscle.
A myosin heavy chain gene, MYHM2528-1, is a potential target to understand the molecular network involved in indeterminate muscle growth due to its specific expression in neonatal muscle fibers produced by this unique process. Here, we examined the promoter activity of the 5′-flanking region of torafugu MYHM2528-1 via an in vivo reporter assay using zebrafish and successfully identified a region that had adequate promoter activity; this promoter participates in induction of gene expression specifically in neonatal muscle fibers produced by hyperplastic muscle growth at larval and post-larval stages of zebrafish development. Despite the phylogenetic distance between zebrafish and torafugu, our results clearly indicate that the signaling cascade responsible for the MYHM2528-1 promoter activity is conserved, suggesting that this molecular cascade is conserved among teleosts.
Notably, there is also a marked difference in adult body size between torafugu (over 6 kg of adult body weight) and zebrafish (4-5 cm of adult body length). Rowlerson et al. (1997) compared production of neonatal muscle fibers at the post-larval stage between sea bream Sparus aurata (large fish) and zebrafish.
Based on the difference in MYH composition in neonatal muscle fibers at the adult stage, they suggested that large and small fish have different genetic requirements for the production of these fibers. Our results, however, clearly showed that the transcriptional network mediating MYH expression in neonatal muscle fibers at larval and post-larval stages is conserved between large (torafugu) and small (zebrafish) fish. However, an important difference is the duration of promoter activity in fast muscle. MYHM2528-1 promoter activity in fast muscle ceased at 40 dpf, 17 mm SL ( Figure 6I ,J,L,M) and 60 dpf, 25 mm SL ( Figure 6O ) of zebrafish in this study, whereas the MYHM2528-1 expression in torafugu fast muscle is still up-regulated at a far larger size (over 1 kg body weight) (Akolkar et al., 2010; Asaduzzaman et al., 2013) . In addition, when compared with the number of MYHM2528-1 expressing muscle fibers in the adult torafugu fast muscle (Akolkar et al., 2010; Asaduzzaman et al., 2013) , the number of EGFP-positive fast muscle fibers in Tg:MYHM2528-1:EGFP zebrafish seemed to be reduced (Fig. 6C,D,G,H) . Because fast muscle occupies a large portion of skeletal muscle in the teleost, the degree of growth in fast muscle is an important factor in determination of adult body size. Nevertheless, we cannot exclude a possibility that torafugu MYHM2528-1 promoter is not sufficient to induce gene expression in all neonatal muscle fibers of zebrafish because of species difference. In this regard, zebrafish ortholog of torafugu MYHM2528-1 has not been identified by syntenic analysis. Johnston et al., (2009) reported the up-regulation of a MYH named myhz1 in small diameter fibers of zebrafish fast muscle. Although our MYHM2528-1 promoter sequence was compared with 5 kb upstream sequence of zebrafish myhz1 paralogs, myhz1.1, myhz1.2 and myhz1.3 by rVISTA program, no homologous region was detected (data not shown).
As mentioned earlier, production of neonatal muscle fibers in teleost fast muscle continues at the post-larval stage but ceases at a definitive size (Johnston, 2001 , Fig. 6B ). Conversely, the growth of teleost slow muscle is 'indeterminate' in a true sense, in which muscle fiber production lasts until death (Johnston, 2001 , Fig. 6B ). Our transgenic line expresses EGFP in both slow and fast muscles at larval (Fig. 5) and early juvenile stages (Fig. 6C-H ) but only in slow muscle at the late juvenile and adult stage (Fig. 6I-Q) . This clear contrast between slow and fast muscles in growth patterns with advancing age is important because sarcopenia in mammals is often accompanied by a conversion of fast muscle fibers to slow muscle fibers (vonHaehling et al., 2010) . What molecular mechanisms determine this difference in the promoter activity between slow and fast muscles is an interesting question with respect to muscle growth and aging.
Our goal was to elucidate the molecular mechanisms responsible for the difference in muscle growth between mammals and teleosts. In mammals, production of neonatal muscle fibers at post-larval stages occurs only during regeneration after injury and disease (Rowe and Goldspink, 1969) . Although it is not clear whether the same signaling is shared between regeneration and growth, common MYHs, both neonatal and embryonic, are expressed in neonatal muscle fibers and produced during adult stage regeneration and embryonic hyperplastic muscle growth in mammals (Lyons et al., 1990; Whalen et al., 1981) . Daou et al. (2013) reported that NFAT signaling is primarily important to induce neonatal and embryonic MYHs in neonatal muscle fibers in the adult mouse. We found that the MYHM2528-1 promoter also contains three putative NFAT binding sites (Figs. 1 and S1 ) and deletion constructs showed an apparent reduction in the promoter activity in accordance with number of the NFAT binding sites (Figs. 2 and 3) . These results suggest NFAT signaling is also involved in the activation of the MYHM2528-1 promoter in the teleost, presenting the possibility that indeterminate muscle growth is due to constitutive activation of NFAT signaling in skeletal muscle. We also found multiple sites for several representative myogenesis-related transcription factors in the promoter sequence (Figs. 1 and S1 ). MyoD and MEF2 are representative myogenic regulatory factors for muscle differentiation (Chanoine et al., 2004) and deletion constructs also demonstrated reduced promoter activity in harmony with number of the MyoD and MEF2 binding sites. Pax3 is expressed in myogenic precursor cells and may be involved in indeterminate muscle growth (Froehlich et al., 2013b) . Therefore, it will be necessary to examine whether all of these factors, including NFAT, are actually involved in the promoter activity and also in the regulation of indeterminate muscle growth. This ambiguity is the next target of our research.
To our knowledge, this study is the first to report the specific promoter involved in teleost indeterminate muscle growth. Although there are intriguing characteristics of teleost indeterminate muscle growth, little is known about the underlying causative molecular mechanisms. Further studies of the MYHM2528-1 promoter such as interactome analysis on the promoter will provide new insights not only into skeletal muscle biology but also into vertebrate growth and aging.
4.
Materials and methods
Experimental fish
The dorsal fin of an adult torafugu T. rubripes (body mass 1 kg) was used for the extraction of genomic DNA. Torafugu larvae at 10 days post-fertilization (dpf) were supplied by the Oshima Fishery Hatchery Co., Ltd, Nagasaki, Japan. Adult zebrafish D. rerio were raised at the zebrafish rearing facility at the Department of Aquatic Bioscience, The University of Tokyo. Fish were maintained at 28°C with a photoperiod of 14 h light and 10 h dark in small aquariums supplied with continuous freshwater in a recirculatory system. Spawning of zebrafish was carried out by placing a pair of males with a pair of females. Embryos and larvae were maintained at 28°C as described previously (Westerfield, 1995) .
Determination of the transcription start site of MYHM2528-1
The 5′-flanking sequence of MYHM2528-1 was retrieved from the Ensemble Fugu Genomic Database (FUGU4.0). A GeneRacer kit (Invitrogen, Carlsbad, CA, USA) was used to define the transcriptional start site of MYHM2528-1 through RNA ligase-mediated rapid amplification of 5′cDNA ends (RLM-RACE). Total RNA from torafugu larvae at 10 dpf was extracted with ISOGEN solution (Nippon Gene, Tokyo, Japan) and treated with calf intestinal phosphatase (CIP). Dephosphorylated RNA was then decapped using tobacco acid pyrophosphatase (TAP) and ligated with GeneRacer RNA oligomers according to the manufacturer's instructions. The 5′cDNA end was amplified by PCR using a MYHM2528-1-specific reverse primer (Table 1) with the GeneRacer 5′primer (Invitrogen) included in the kit. Amplified 5′cDNA fragments were subcloned into the pGEM-T vector (Promega, Madison, WI, USA) and sequenced with an ABI 3100 genetic analyzer (Applied Biosystems, CA, USA) after labeling with the ABI PRISM BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems). Screening of putative transcription binding sites in the 5′-flanking region was carried out by Genomatix (http://www.genomatix.de), the TFSEARCH program (www .cbrc.jp/research/db/TFSEARCH.html) and the manual identification.
Construction of reporter vector
To identify the minimal promoter, a series of 5′ deletion constructs within the 5000 bp flanking region from the start codon of MYHM2528-1 was generated by PCR using torafugu genomic DNA as a template. A total nine forward primers and one reverse primer were designed (Table 1) to amplify the 5000 bp and a series of 5′ distal deletion regions. All of these amplified PCR products were inserted individually into the BamHI-XhoI site of the Tol2-EGFP reporter vector named pT2AL200R150G (courtesy of Dr. Koichi Kawakami) by In-Fusion Advantage PCR Cloning (Clontech, CA, USA). The plasmid DNA for microinjection was isolated from each deletion construct using the GenElute TM plasmid mini-prep kit (Sigma-Aldrich, Steinheim, USA). These constructs were named as P5000, P4000, P3000, P2500, P2300, P2100, P1500, P1000, and P600, where the numbers refer to the nucleotide positions upstream of the MYHM2528-1 start codon (Fig. 1) . All constructs contained a MYHM2528-1 flanking region conjugated with the EGFP reporter gene, SV40 polyA signal, and Tol2 transposase binding sites.
4.4.
In vivo reporter assay
Each EGFP reporter construct was diluted to 100 ngµL −1 with sterile distilled water containing 0.025% phenol red and injected into fertilized zebrafish eggs at one-to two-cell stages. Microinjection was performed using the IM300 microinjector (Narishige, Tokyo, Japan). Embryos were reared at 28°C and EGFP expression patterns were observed under a MVX10 macrozoom microscope (Olympus, Tokyo, Japan) and a FV1000 confocal laser scanning microscope (Olympus). Fish were anesthetized with 0.6 µM tricainemethane-sulfonate (Sigma-Aldrich) to inhibit movement during observation.
Generation of theTg:MYHM2528-1:EGFP transgenic line
RNA encoding a functional Tol2 transposase enzyme was transcribed in vitro from pCS-TP vector (Kawakami et al., 2000 (Kawakami et al., , 2004 . The Tol2-based construct (P2100) was co-injected with P5000F  TTGGGCCCGGCTCGAGGACCAGTGCGGAGGGACAGA  36  P4000F  TTGGGCCCGGCTCGAGTGTAGGATTCCAACCTATTTGGTCT  41  P3000F  TTGGGCCCGGCTCGAGCCACTGTGATACTGAATAATAAGGG  41  P2500F  TTGGGCCCGGCTCGAGGAAGATACATAAGATGTCCCTGACT  41  P2300F  TTGGGCCCGGCTCGAGCAAGGGGCAAACCTCCAGCACT  38  P2100F  TTGGGCCCGGCTCGAGGCTGCAGAATTAGTGTGAATGACATAT  43  P1500F  TTGGGCCCGGCTCGAGATTATATCTTGCTGGTAATCACTTCAGAATTTC  49  P1000F  TTGGGCCCGGCTCGAGTACTGCCAAAGAGCATAAAAGAGATGC  43  P600F  TTGGGCCCGGCTCGAGTGCACAAGCGCAGCACAACCC  37  Reverse  GGCGACCGGTGGATCCGATGGCTCTTTACTGCACAAGCACAAA  43  5′RACE MYHM2528-1 specific reverse primer GAA GAT TTC ATC GTC TTT CAC AGT G 25 transposase mRNA into one-to two-cell stage embryos. At 8-10 h post-microinjection, embryos were subjected to Transient Embryonic Excision Assay (TEEA) to confirm whether the excision occurred properly. Following a successful TEEA, the EGFP-positive embryos were identified at 1 dpf and then transferred into the fish rearing unit at the Department of Aquatic Bioscience, The University of Tokyo, until sexual maturity. Individual founder fish were outcrossed with wild-type fish for examination of EGFP-positive expression in the offspring. EGFPpositive offspring of selected founder lines were raised to establish the F1 generation. The F2 generation was then established by intercrossing F1 fish.
Immunohistochemistry and antibodies
For immunohistochemistry, larvae and juveniles of the transgenic line were fixed with 4% PFA in Tris-buffered saline (25 mM Tris-HCl [pH 7.4], 137 mM NaCl, 2.7 mM KCl) containing 0.1% Tween 20 (TBSTw) overnight at 4°C. Fixed samples were washed with TBSTw and blocked using a 1.5% blocking reagent (Roche Applied Science) in TBSTw. Transverse sections were prepared at a thickness of 16 µm with a cryostat Tissue-Tek Cryo3 (Sakura Finetech, Tokyo, Japan) at −20°C before the first immunoreactions. The primary antibodies used in this study were as follows: the EGFP antibody (Clontech, CA, USA) was used at a dilution of 1:1000 in the blocking solution, and F310 (fast muscle fiber-specific), F59 (slow muscle fiber-specific), and MF20 (striated muscle-specific) antibodies supplied by Developmental Studies Hybridoma Bank (Iowa city, IA, USA) at 1:20. Immunoreaction with the primary antibody was performed overnight at 4°C. After incubation, embryos were washed with TBSTw and labeled with the secondary antibodies, antimouse IgG Alexa Fluor 555 and anti-rabbit IgG Alexa Fluor 488 (Invitrogen), at a dilution of 1:250 overnight at 4°C. The embryos were subsequently washed with TBSTw and labeled with DAPI (Invitrogen). EGFP was also observed using staining of the tissue section with 5 mM BODIPY TR ceramide (Molecular Probes) at room temperature for 30 min. The signals in the cryosection samples were viewed using an Olympus FluoView1000 confocal laser scanning microscope (Olympus).
Cyclopamine treatment
Tg:MYHM2528-1:EGFP embryos at two-to four-cell stages were transferred into 2, 4, 6, and 10 µg mL −1 cyclopamine solution (Wako, Otsu, Japan) containing 0.2%, 0.4%, 0.6% and 1.0% ethanol and incubated at 28.5°C. Control embryos were developed in 0.02, 0.04, 0.06 and 0.1% ethanol, respectively, containing water without cyclopamine. EGFP expression in cyclopamine-treated and untreated control embryos was observed from 2-3 dpf using a MVX10 macro-zoom microscope (Olympus).
Data and statistical analyses
To compare the percentages of embryos with EGFP expression in skeletal and craniofacial muscles in various constructs and the relative quantification of target gene, statistical analyses were conducted using a one-way analysis of variance (ANOVA) followed by Tukey's test in the Statistical Package for Social Science (SPSS) version 11.5. Data were represented as the mean ± SD and the differences were considered significant at P < 0.05.
